Page 32 - Biological E News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India's Biological E looking to make 600 mn J&J vaccine shots a year: CEO Synopsis The country's inoculation drive is currently using the Oxford University-AstraZeneca vaccine and another developed at home by Bharat Biotech with the state-run Indian Council of Medical Research. Agencies Indian pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson's COVID-19 vaccine annually, its managing director told Reuters on Wednesday. The country's inoculation drive is currently using the Oxford University-AstraZeneca vaccine and anoth...

Why Johnson & Johnson's Covid-19 vaccine is generating a lot of interest Initial reports indicate the vaccine elicits a very good response. The single-dose vaccine can prove to be a gamechanger, especially in a country with a large population, such as India, where two doses will consume tremendous resources January 18, 2021 / 05:11 PM IST With Johnson & Johnson (J&J)'s COVID-19 vaccine Phase-3 clinical trial data expected to be announced before the end of January, followed by an application for Emergency Use Authorization in the US and other countries, another vaccine may soon  become av...